Rite Aid Hopes For Greener Pastures After Cutting Grass
Executive Summary
Rite Aid will be operating under a one-year turnaround deadline following the departure of CEO Martin Grass and the infusion of $300 mil. from Leonard Green & Partners.
You may also be interested in...
Rite Aid Sales Slow With OTC Claritin, HRT Slump; Growing Rx Count Is Focus
Rite Aid is attributing its slower growth in prescription drug sales to reduced hormone therapy demand and the Claritin OTC switch
Rite Aid Allegations Include Booking Unearned Rx Rebates By Former Exec
Improper recording of contingent pharmaceutical rebates is among the allegations in a criminal indictment against one current and three former Rite Aid executives
Rite Aid Allegations Include Booking Unearned Rx Rebates By Former Exec
Improper recording of contingent pharmaceutical rebates is among the allegations in a criminal indictment against one current and three former Rite Aid executives